Back to top
more

Neogen (NEOG)

(Delayed Data from NSDQ)

$14.44 USD

14.44
1,190,769

+0.16 (1.12%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $14.45 +0.01 (0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (74 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Neogen (NEOG) Q3 Earnings and Revenues Lag Estimates

Neogen (NEOG) delivered earnings and revenue surprises of -14.29% and 0.49%, respectively, for the quarter ended February 2024. Do the numbers hold clues to what lies ahead for the stock?

Neogen (NEOG) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Neogen (NEOG), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended February 2024.

Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates

Exagen Inc. (XGN) delivered earnings and revenue surprises of 24.39% and 20.40%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Ayr Wellness Inc. (AYRWF) Reports Q4 Loss, Misses Revenue Estimates

Ayr Wellness Inc. (AYRWF) delivered earnings and revenue surprises of -38.46% and 0.10%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Here's Why You Should Hold on to Neogen (NEOG) Stock Now

Solid progress in long-term growth strategies bodes well for Neogen (NEOG).

Why Is Neogen (NEOG) Down 14.6% Since Last Earnings Report?

Neogen (NEOG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Retain Neogen (NEOG) Stock for Now

Investors are optimistic about Neogen (NEOG) on strong growth in Animal and Food Safety businesses.

Neogen's (NEOG) Q2 Earnings Miss Estimates, 2024 View Down

Neogen's (NEOG) Q2 revenues decline year over year due to lower Animal Safety business.

Company News for Jan 10, 2024

Companies in The News Are: U,JNPR,HPE,AYI,NEOG

Neogen (NEOG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Neogen (NEOG) give insight into how the company performed in the quarter ended November 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Indrajit Bandyopadhyay headshot

4 Medical Product Stocks to Buy Amid Industry Challenges

Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. PHG, NEOG, HAE and PBH are well-poised to gain from the favorable factors.

Quipt Home Medical Corp. (QIPT) Reports Q4 Loss, Misses Revenue Estimates

Quipt Home Medical Corp. (QIPT) delivered earnings and revenue surprises of -250% and 1.69%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Neogen (NEOG) to Advance Feline DNA Testing With New Pact

Neogen's (NEOG) strategic alliance will expand feline DNA testing and strengthen its relationship with the kitty community.

Here's Why You Should Buy Neogen (NEOG) Stock Now

Investors are optimistic about Neogen (NEOG), owing to product launches and the performance of segments.

Neogen (NEOG) to Offer Biosecurity Products With New Pact

Neogen will be able to highlight its biosecurity and horse health products, like the COMPANION range of cleansers and disinfection solutions, through the latest collaboration.

Neogen (NEOG) Unveils New Assay for Walnut Allergens Detection

Neogen's (NEOG) Veratox VIP for Walnut allergy test displays robust performance across sample types while keeping the Veratox product line's simple testing approach.

Abbott (ABT) Up 5.1% Since Last Earnings Report: Can It Continue?

Abbott (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Neogen's (NEOG) Innovation Aids, Currency Headwind Stays

Neogen (NEOG) is progressing well in terms of picking the right growth markets and gaining a bigger share of those markets.

Neogen (NEOG) Up 3.6% Since Last Earnings Report: Can It Continue?

Neogen (NEOG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Neogen's (NEOG) Q1 Earnings Miss Estimates, Margins Rise

Neogen's (NEOG) Q1 Animal Safety business experiences continued destocking, with channel inventory levels reaching multi-year lows.

Company News for Oct 11, 2023

Companies in The News Are: PEP,NEOG,PLTR,TFC

Neogen (NEOG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Neogen (NEOG) give a sense of how the business performed in the quarter ended August 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Here's Why Neogen (NEOG) is Poised for a Turnaround After Losing -14.43% in 4 Weeks

Neogen (NEOG) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Neogen (NEOG) Lags Q1 Earnings and Revenue Estimates

Neogen (NEOG) delivered earnings and revenue surprises of -21.43% and 1.23%, respectively, for the quarter ended August 2023. Do the numbers hold clues to what lies ahead for the stock?

Here's Why You Should Invest in Neogen (NEOG) Stock Now

Investors are optimistic about Neogen (NEOG), led by progress in the Food Safety business and recent product launches.